Skip to content
10-K

Annual Report

REGENEREX PHARMA, INC. RGPX

0001472375-24-000045

← back to feed
Filed
Jun 24, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jun 24, 2024 278.23M sh
Operating Cash Flow FY 2023 · Mar 31, 2023 −$76.16K
Cash And Equivalents FY 2023 · Mar 31, 2023 $1.14K
Current Liabilities FY 2023 · Mar 31, 2023 $776.78K
Total Liabilities FY 2023 · Mar 31, 2023 $1.13M
Current Assets FY 2023 · Mar 31, 2023 $1.14K
Total Assets FY 2023 · Mar 31, 2023 $6.54K
Net Income FY 2023 · Mar 31, 2023 −$137.33K
Operating Income FY 2023 · Mar 31, 2023 −$96.17K
Stockholders Equity FY 2023 · Mar 31, 2022 −$985.62K